Free Account Opening + AMC Free Demat
Loading...
Ajooni Biotech Rights Issue 2024 Detail
Issue Open May 21, 2024
Issue Close May 31, 2024
Issue Size (Shares) 8.76 Crores
Issue Size (Amount) ₹43.81 Crores
Issue Price ₹5 per Share
Listing At NSE
  1. Ajooni Biotech Ltd (AJOO)

    October 29, 2024 4:00:00 PM

    Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

    Published by : Investing
  2. November 2024 Issue

    October 29, 2024 1:04:00 PM

    Purchase Current Issue or Login to Download the PDF of this Issue Download the PDF of this Issue What’s worse than taking illegal foreign campaign contributions? Mayor Eric Adams’s failure to ...

    Published by : The Nation
  3. EQS-News: BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology

    October 31, 2024 10:12:00 PM

    BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology BRAIN can receive up to EUR 92.3 million R&D and commercial milestone fees ...

    Published by : Business Insider
  4. Roche tosses out tau prospect, returning rights to UCB 4 years after placing $120M bet

    October 22, 2024 12:00:00 PM

    Roche has returned the rights to UCB’s anti-tau antibody bepranemab ... UCB granted Roche and its biotech unit Genentech an exclusive worldwide license to bepranemab, then called UCB0107 ...

    Published by : FierceBiotech
  5. FBN Holdings Set to Raise N150bn Via Rights Issue

    October 28, 2024 7:36:00 AM

    FBN Holdings Plc yesterday said it had commenced plans to raise N150 billion from its existing shareholders by way of rights issue. The Holdings recently held the signing ceremony to commence ...

    Published by : This Day
  6. Edison issues report on BB Biotech (BION)

    October 23, 2024 7:41:00 AM

    London, UK, 23 October 2024 Edison issues report on BB Biotech (BION) Edison issues report on BB Biotech (BION). BB Biotech (BION) invests in innovative, rapidly expanding biotech companies.

    Published by : Business Insider
  7. Environmental Issues News

    October 28, 2024 3:30:00 AM

    Oct. 28, 2024 — A new study used the 2023 heat wave in Texas and Louisiana as a test case for establishing processes that tease out whether particular weather events are climate change ...

    Published by : Science Daily
  8. Abortion News

    October 28, 2024 10:27:00 AM

    By Margot Sanger-KatzClaire Cain Miller and Eve Washington They hope the issue helps their candidates. But some voters may support Republican candidates as well as abortion-rights ballot measures.

    Published by : The New York Times
  9. Election 2024: Women’s Rights

    October 30, 2024 3:31:00 AM

    WASHINGTON (Gray DC) - Women’s rights are one of the most important issues on the ballot for Election 2024. In June 2022, the U.S. Supreme Court effectively overturned the right to access ...

    Published by : 19 Action News
  10. On the Issues: What the Presidential Candidates Have Said About Immigration

    October 23, 2024 3:30:00 AM

    While they differ in their approach, some see a convergence between the two main presidential candidates when it comes to border policy, noting with surprise that Vice President Harris has put forth ...

    Published by : City Limits
  11. Medpace Earnings: Shares Fall Due to Cancellations From Biotech Funding Issues

    October 22, 2024 3:30:00 AM

    Medpace reported mixed third-quarter results, as revenue increased 8.3% from the prior-year period but net new business awards decreased 12.7% due to elevated cancellations. This resulted in a net ...

    Published by : Morningstar

Read Ajooni Biotech Rights Issue 2024 current news. Find Ajooni Biotech Rights Issue 2024 subscription news, Rights Issue analysis, broker reviews, allotment news, and listing date. Get the Ajooni Biotech Limited Rights Issue grey market premium and Ajooni Biotech Rights Issue 2024 expected listing price.